G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 523.05 INR 0.11% Market Closed
Market Cap: 429.8B INR
Have any thoughts about
Glenmark Pharmaceuticals Ltd?
Write Note

Glenmark Pharmaceuticals Ltd
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Pharmaceuticals Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Goodwill
â‚ą673.6m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
1%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Goodwill
â‚ą5.5B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Goodwill
â‚ą32.5B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Goodwill
â‚ą87.7B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
14%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Goodwill
â‚ą3.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
36%
M
Mankind Pharma Ltd
NSE:MANKIND
Goodwill
â‚ą200.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Glenmark Pharmaceuticals Ltd
Glance View

Market Cap
429.8B INR
Industry
Pharmaceuticals

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The firm is primarily engaged in the business of developing, manufacturing and marketing of pharmaceutical products. The company focuses on manufacturing products across therapeutic areas of respiratory, dermatology and oncology. The company is involved in development of new chemical entities (NCEs) and new biological entities (NBEs). Its business segments include India, North America, Europe and Rest of the world. The company is focused on developing and marketing branded and generic formulations. Its products include FabiFlu, Ryaltris and Remo (Remogliflozin etabonate). Its FabiFlu is an antiviral medication to treat mild to moderate COVID-19. Its Ryaltris is a fixed-dose combination nasal spray of an antihistamine (olopatadine hydrochloride 665 microgram) and a steroid that treats symptoms associated with seasonal, as well as perennial allergic rhinitis. Its Remo is a sodium-glucose transport-2 (SGLT2) inhibitor for the type 2 diabetes.

GLENMARK Intrinsic Value
1 022.69 INR
Overvaluation 33%
Intrinsic Value
Price
G

See Also

What is Glenmark Pharmaceuticals Ltd's Goodwill?
Goodwill
673.6m INR

Based on the financial report for Jun 30, 2024, Glenmark Pharmaceuticals Ltd's Goodwill amounts to 673.6m INR.

What is Glenmark Pharmaceuticals Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
1%

Over the last year, the Goodwill growth was -9%. The average annual Goodwill growth rates for Glenmark Pharmaceuticals Ltd have been 5% over the past three years , 4% over the past five years , and 1% over the past ten years .

Back to Top